Literature DB >> 7742220

Urinary calcium and oxalate excretion in children.

G S Reusz1, M Dobos, D Byrd, P Sallay, M Miltényi, T Tulassay.   

Abstract

We have established normal values for calcium/creatinine (Ca/Cr) and oxalate/creatinine (Ox/Cr) ratios in 25 infants (aged 1-7 days) and 391 children (aged 1 month to 14.5 years) and compared these with values obtained in 137 children with post-glomerular haematuria and 27 with nephrolithiasis. Oxalate was measured by ion chromatography. Nomograms of Marshall and Robertson were used to calculate urine saturation to calcium oxalate. The Ca/Cr ratio was normally distributed whereas the Ox/Cr ratio had a log-normal distribution. The molar ratio of Ca/Cr was the lowest in the first days of life and the highest between 7 month and 1.5 years (mean +/- SD = 0.39 +/- 0.28 mmol/mmol). Following a slight decrease it stabilised by the age of 6 years (0.34 +/- 0.19 mmol/mmol). The highest Ox/Cr values were measured during the 1st month of life [geometric mean 133 (range 61-280) mumol/mmol], followed by a gradual decrease until 11 years of age [mean 24 (range 6-82) mumol/mmol]. Thirty-six haematuric children had hypercalciuria (26%), 23 had absorptive hypercalciuria, 13 renal type. Children with absorptive hypercalciuria on a calcium-restricted diet had significantly higher oxalate excretion than those with renal hypercalciuria and the control group [38 (range 28-49) vs. 22 (range 16-29) and 23 (range 22-27) mumol/mol respectively, P < 0.01]. Calcium oxalate urine saturation of stone patients was higher than that of patients with haematuria and the normal population (1.18 +/- 0.05 vs. 1.06 +/- 0.03, P < 0.03 and 0.84 +/- 0.03, P < 0.001 respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742220     DOI: 10.1007/BF00858966

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  38 in total

Review 1.  Factors governing urinary tract stone disease.

Authors:  R W Watts
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

2.  Urinary excretion of magnesium and calcium in normal children.

Authors:  L Paunier; M Borgeaud; M Wyss
Journal:  Helv Paediatr Acta       Date:  1970-12

3.  Idiopathic hypercalciuria: association with isolated hematuria and risk for urolithiasis in children. The Southwest Pediatric Nephrology Study Group.

Authors:  F B Stapleton
Journal:  Kidney Int       Date:  1990-02       Impact factor: 10.612

4.  Determination of urinary oxalate by ion chromatography: preliminary observation.

Authors:  C J Mahle; M Menon
Journal:  J Urol       Date:  1982-01       Impact factor: 7.450

5.  Determination of oxalate excretion in spot urines of healthy children by ion chromatography.

Authors:  C von Schnakenburg; D J Byrd; K Latta; G S Reusz; D Graf; J Brodehl
Journal:  Eur J Clin Chem Clin Biochem       Date:  1994-01

6.  Hypercalciuria in children with hematuria.

Authors:  F B Stapleton; S Roy; H N Noe; G Jerkins
Journal:  N Engl J Med       Date:  1984-05-24       Impact factor: 91.245

7.  Family investigations in idiopathic hypercalciuria.

Authors:  F Harangi; K Méhes
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

8.  Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets.

Authors:  G S Reusz; K Latta; P F Hoyer; D J Byrd; J H Ehrich; J Brodehl
Journal:  Lancet       Date:  1990-05-26       Impact factor: 79.321

9.  The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria?

Authors:  W G Robertson; M Peacock
Journal:  Nephron       Date:  1980       Impact factor: 2.847

10.  Gas-chromatographic estimation of urinary oxalate and its comparison with a colorimetric method.

Authors:  C J Farrington; A H Chalmers
Journal:  Clin Chem       Date:  1979-12       Impact factor: 8.327

View more
  24 in total

1.  Spot urine samples for evaluating solute excretion in the first week of life.

Authors:  V Matos; A Drukker; J P Guignard
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-05       Impact factor: 5.747

2.  Urinary calcium to creatinin ratio in children.

Authors:  Hadi Sorkhi; Mahmmod Haji Aahmadi
Journal:  Indian J Pediatr       Date:  2005-12       Impact factor: 1.967

3.  Nephrocalcinosis in preterm babies.

Authors:  A Narendra; M P White; H A Rolton; Z I Alloub; G Wilkinson; J H McColl; J Beattie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-11       Impact factor: 5.747

4.  Screening for hypercalciuria in schoolchildren: what should be the criteria for diagnosis?

Authors:  Mustafa Koyun; Ayfer Gür Güven; Serkan Filiz; Sema Akman; Halide Akbas; Yunus Emre Baysal; Necati Dedeoglu
Journal:  Pediatr Nephrol       Date:  2007-06-05       Impact factor: 3.714

Review 5.  The biochemical diagnosis of Gitelman disease and the definition of "hypocalciuria".

Authors:  Mario G Bianchetti; Alberto Edefonti; Alberto Bettinelli
Journal:  Pediatr Nephrol       Date:  2003-05       Impact factor: 3.714

6.  Ask the expert: what is the appropriate work-up for a child with hypercalciuria?

Authors:  J R Burke
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

7.  Urinary calcium excretion in healthy Turkish children.

Authors:  F Sönmez; B Akçanal; Ayça Altincik; C Yenisey
Journal:  Int Urol Nephrol       Date:  2006-10-17       Impact factor: 2.370

8.  Urinary oxalate excretion in urolithiasis and nephrocalcinosis.

Authors:  T J Neuhaus; T Belzer; N Blau; B Hoppe; H Sidhu; E Leumann
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

9.  Rupture of undiagnosed embryonal rhabdomyosarcoma after shock wave lithotripsy in an 11-year-old girl.

Authors:  Yu Seob Shin; Young Gon Kim; Kyu Yun Jang; Hwang Choi; Hyung Jin Kim
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

10.  Urinary mineral excretion in healthy Iranian children.

Authors:  Mohammad R Safarinejad
Journal:  Pediatr Nephrol       Date:  2002-12-21       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.